The global brain cancer treatment market is rapidly evolving, driven by the increasing incidence of brain cancer and advancements in medical technology focusing on personalized medicine. With ...

The Interleukin-2 (IL-2) market is witnessing rapid growth due to advancements in cancer immunotherapy and autoimmune disease management. IL-2, a vital cytokine, promotes T-cell growth, with therapies ...

Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized ...

In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

Researchers at the University of Texas at Dallas, led by bioengineering associate professor Dr. Girgis Obaid, are partnering ...

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum ...

Unfortunately, they can't usually cure the cancer. Whether you have targeted therapy or immunotherapy depends on: genetic changes in the cancer cells how far the cancer has grown (the stage) other ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...

At the cutting edge of TIL therapy development, Creative Biolabs offers end-to-end and integrated solutions dedicated to the unique needs of this dis ...